The GCR Interactive: Pharmaceuticals will be taking place on Zoom.
Paul Harris QC will be speaking on the panel covering Class Certification. Pharma antitrust litigation often centres on billions of dollars of exposure. The size of these cases has focused appellate courts keenly on the proper standards for certification of class actions. The recent Asacol case has led courts to be more cautious in granting class certification in pharmaceutical and other antitrust cases. With the U.S. Supreme Court recently granting petitions of certiorari on fundamental class action issues such as actual injury, this session will consider what criteria is affecting these analyses and whether they have been thorough enough.